I have been monitoring a few biostocks for a while, and have decided that LBT offers one of the best propositions on the market. This investment is extremely compelling for many many reasons.
LBT is on the forefront of filling some existing market gaps, and the competition to date, appears limited. Infact, I am surprised that pathology diagnostics is so labour intensive and, so subject to human interpretation (and error!). The industry does not seem to have evolved and capitalised on modern technology (yet!).
Regardless, anything that offers more accurate diagnosis and more cost efficient processing of samples than the status quo will set a new benchmark. To remain competitive, diagnostic labs will be forced to adopt the best technology that minimises their costs and reduces their risks, and LBT is at the forefont.
LBT's agreements with global suppliers of medical technology such as bioMérieux and Hettich guarantee access to the global market. There is no need for LBT to waste enormous resources on marketing and pushing sales. They just have to get on with product development and/or future product enhancement!
I am also attracted by the potential for further product development and growth (biopsies, cell therapy, cancer...). The need for diagnostics will only get bigger as populations age and people live longer.
The ARC grant is a real vote of confidence for the company. I am sure the panel of experts thoroughly examined the potential for all sorts of products, and decided that LBT was a goer!
Like you Furniture, I am sick of capital raisings and dilutions and trading halts (you never know when it will end). In my experience thus far, the news has been inevitably bad (BBG springs to immediate mind, but there are plenty more). I am a lot more cautious now and keep an eye on the balance sheet. LBT's prudent approach to date is attractive for me, and shows that management and the Board are responsible with shareholder's money.
Does anyone know when/where the AGM's are held?
- Forums
- ASX - By Stock
- Ann: LBT wins grant for APAS development
I have been monitoring a few biostocks for a while, and have...
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $24.11M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $12.19K | 662.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 540547 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 540547 | 0.018 |
4 | 501203 | 0.017 |
3 | 413821 | 0.016 |
1 | 65000 | 0.014 |
2 | 121999 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 100000 | 1 |
0.021 | 641618 | 2 |
0.022 | 69342 | 1 |
0.023 | 664488 | 4 |
0.024 | 900000 | 7 |
Last trade - 14.01pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
1.9¢ |
  |
Change
-0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
1.9¢ | 1.9¢ | 1.9¢ | 139 | ||
Last updated 11.29am 07/05/2024 ? |
Featured News
LBT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online